224 related articles for article (PubMed ID: 1738001)
41. Renal adenosine A1 receptor binding characteristics and mRNA levels during the development of acute renal failure in the rat.
Gould J; Morton MJ; Sivaprasadarao A; Bowmer CJ; Yates MS
Br J Pharmacol; 1997 Mar; 120(5):947-53. PubMed ID: 9138703
[TBL] [Abstract][Full Text] [Related]
42. G-protein-coupled A1 adenosine receptors in coated vesicles of mammalian brain: characterization by radioligand binding and photoaffinity labelling.
González-Calero G; Cubero A; Klotz KN
Cell Signal; 1992 Nov; 4(6):737-45. PubMed ID: 1489663
[TBL] [Abstract][Full Text] [Related]
43. Potential use of DPCPX as probe for in vivo localization of brain A1 adenosine receptors.
Bisserbe JC; Pascal O; Deckert J; Mazière B
Brain Res; 1992 Dec; 599(1):6-12. PubMed ID: 1493550
[TBL] [Abstract][Full Text] [Related]
44. The binding of the adenosine A2 receptor selective agonist [3H]CGS 21680 to rat cortex differs from its binding to rat striatum.
Johansson B; Georgiev V; Parkinson FE; Fredholm BB
Eur J Pharmacol; 1993 Oct; 247(2):103-10. PubMed ID: 8281998
[TBL] [Abstract][Full Text] [Related]
45. Adenosine receptors in cortical-derived vesicles of the rat: studies on binding sites and accumulation of cyclic AMP.
Florio C; Rosati AM; Traversa U; Vertua R
Neuropharmacology; 1990 Apr; 29(4):387-97. PubMed ID: 2160626
[TBL] [Abstract][Full Text] [Related]
46. Characterization of adenosine receptors in the PC12 pheochromocytoma cell line using radioligand binding: evidence for A-2 selectivity.
Williams M; Abreu M; Jarvis MF; Noronha-Blob L
J Neurochem; 1987 Feb; 48(2):498-502. PubMed ID: 3794718
[TBL] [Abstract][Full Text] [Related]
47. Chronic theophylline exposure increases agonist and antagonist binding to A1 adenosine receptors in rat brain.
Sanders RC; Murray TF
Neuropharmacology; 1988 Jul; 27(7):757-60. PubMed ID: 3419552
[TBL] [Abstract][Full Text] [Related]
48. Regulation of agonist binding to A2A adenosine receptors: effects of guanine nucleotides (GDP[S] and GTP[S]) and Mg2+ ion.
Mazzoni MR; Martini C; Lucacchini A
Biochim Biophys Acta; 1993 Dec; 1220(1):76-84. PubMed ID: 8268248
[TBL] [Abstract][Full Text] [Related]
49. The ontogenetic profiles of the pre- and postjunctional adenosine receptors in the rat vas deferens.
Peachey JA; Brownhill VR; Hourani SM; Kitchen I
Br J Pharmacol; 1996 Mar; 117(6):1105-10. PubMed ID: 8882603
[TBL] [Abstract][Full Text] [Related]
50. Cyclohexyladenosine binding in rat striatum.
Lloyd HG; Stone TW
Brain Res; 1985 May; 334(2):385-8. PubMed ID: 2986787
[TBL] [Abstract][Full Text] [Related]
51. Affinity of central adenosine A1 receptors is decreased in spontaneously hypertensive rats.
Matias A; Zimmer FJ; Lorenzen A; Keil R; Schwabe U
Eur J Pharmacol; 1993 Feb; 244(3):223-30. PubMed ID: 8458399
[TBL] [Abstract][Full Text] [Related]
52. Identification and characterization of adenosine A1 receptor-cAMP system in human glomeruli.
Toya Y; Umemura S; Iwamoto T; Hirawa N; Kihara M; Takagi N; Ishii M
Kidney Int; 1993 Apr; 43(4):928-32. PubMed ID: 8386781
[TBL] [Abstract][Full Text] [Related]
53. Dissociation between adenosine receptors and adenylate cyclase in the smooth muscle of guinea pig myometrium.
Smith MA; Silverstein JL; Westfall DP; Buxton IL
Cell Signal; 1989; 1(4):357-65. PubMed ID: 2642029
[TBL] [Abstract][Full Text] [Related]
54. PD 115,199: an antagonist ligand for adenosine A2 receptors.
Bruns RF; Fergus JH; Badger EW; Bristol JA; Santay LA; Hays SJ
Naunyn Schmiedebergs Arch Pharmacol; 1987 Jan; 335(1):64-9. PubMed ID: 3574493
[TBL] [Abstract][Full Text] [Related]
55. Differential alterations in adenosine A1 and kappa 1 opioid receptors in the striatum in Alzheimer's disease.
Ikeda M; Mackay KB; Dewar D; McCulloch J
Brain Res; 1993 Jul; 616(1-2):211-7. PubMed ID: 8395303
[TBL] [Abstract][Full Text] [Related]
56. Subchronic treatment with methamphetamine and phencyclidine differentially alters the adenosine A1 and A2A receptors in the prefrontal cortex, hippocampus, and striatum of the rat.
Shirayama Y; Hashimoto K; Higuchi T; Minabe Y
Neurochem Res; 2001 Apr; 26(4):363-8. PubMed ID: 11495346
[TBL] [Abstract][Full Text] [Related]
57. Effects of divalent cations on adenosine agonist binding to A1 receptors and non-A1/non-A2 sites in rat cerebral cortex.
Traversa U; Rosati AM; Florio C; Vertua R
Pharmacol Toxicol; 1994 Jul; 75(1):28-35. PubMed ID: 7971732
[TBL] [Abstract][Full Text] [Related]
58. Indirect effect of guanine nucleotides on antagonist binding to A1 adenosine receptors: occupation of cryptic binding sites by endogenous vesicular adenosine.
Prater MR; Taylor H; Munshi R; Linden J
Mol Pharmacol; 1992 Nov; 42(5):765-72. PubMed ID: 1435751
[TBL] [Abstract][Full Text] [Related]
59. Characterization of a low affinity binding site for N6-substituted adenosine derivatives in rat testis membranes.
Mazzoni MR; Buffoni RS; Giusti L; Lucacchini A
J Recept Signal Transduct Res; 1995; 15(7-8):905-29. PubMed ID: 8673723
[TBL] [Abstract][Full Text] [Related]
60. Chemical modification of adenosine A1 receptors. Implications for the interaction with R-PIA, DPCPX and amiloride.
Garritsen A; Ijzerman AP; Beukers MW; Soudijn W
Biochem Pharmacol; 1990 Aug; 40(4):835-42. PubMed ID: 2143656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
